Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Takara Co., Ltd., commonly referred to as Takara, is a prominent Japanese company specialising in pharmaceutical preparation manufacturing. Headquartered in Japan, the firm operates across key regions, serving the global healthcare and biotechnology sectors. Established in 1954, Takara has a long-standing history of innovation within the pharmaceutical industry, with notable milestones in product development and manufacturing excellence.
The company's core offerings include high-quality pharmaceutical preparations, biotechnological products, and laboratory reagents, distinguished by their precision and reliability. Takara’s commitment to advancing medical research and healthcare solutions has positioned it as a trusted leader in the industry. With a strong market presence and a reputation for quality, Takara continues to contribute significantly to pharmaceutical and biotech advancements worldwide.
-9 vs industry average
Takara’s score of 33 is lower than 46% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Takara's climate commitments focus on reducing emissions intensity, aiming to achieve 50% of fiscal year 2019's emissions per unit of revenue by fiscal year 2026.
For fiscal year 2025, Takara reported approximately 14.18 million kg CO2e for Scope 1 and 2 emissions. This follows fiscal year 2024 with approximately 14.21 million kg CO2e in Scope 1 and 2 emissions, and fiscal year 2023 with approximately 15.69 million kg CO2e in Scope 1 and 2 emissions.
In fiscal year 2022, Scope 1 and 2 emissions were approximately 14.25 million kg CO2e. This is a decrease from fiscal year 2021, which recorded approximately 12.84 million kg CO2e for Scope 1 and 2 emissions. Prior to this, fiscal year 20
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more